PBLOF yields 5.83% · JNJ yields 2.13%● Live data
📍 PBLOF pulled ahead of the other in Year 1
Combined, PBLOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PBLOF + JNJ for your $10,000?
Public Bank Berhad engages in the banking activities. The company's deposit products include savings, current, fixed deposit, foreign currency, and safe deposit box services. Its loan portfolio comprises home, SWIFT, working capital, SME, and other loans; overdrafts; project and vehicle financing; PB retail negotiable instruments of deposit; and credit guarantee corporation guarantee schemes and BNM funds. The company also provides Islamic banking, share broking, trustee services, nominee services, unit trust funds sales and management, bancassurance, and general insurance products and services. In addition, it offers mobile, internet, and self-service banking services; credit and debit card, and remittance services; and investment products and services, such as structured product investment and share trading/margin financing. Further, the company provides insurance products, including single premium investment-linked, family and savings, micro protection, and credit life insurance products. The company operates through a network of 443 branches and 2,078 self-service terminals in Malaysia, as well as 32 branches in Hong Kong, 5 in China, 31 in Cambodia, 29 in Vietnam, 4 in Laos, and 3 in Sri Lanka. It serves retail consumers, and small and medium enterprises. Public Bank Berhad was founded in 1966 and is headquartered in Kuala Lumpur, Malaysia.
Full PBLOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.